首页> 外文期刊>Journal of the American Medical Directors Association >Mortality following nursing home-acquired lower respiratory infection: LRI severity, antibiotic treatment, and water intake.
【24h】

Mortality following nursing home-acquired lower respiratory infection: LRI severity, antibiotic treatment, and water intake.

机译:护理院获得的下呼吸道感染后的死亡率:LRI严重程度,抗生素治疗和饮水量。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In some nursing home populations, antibiotic treatment may not reduce mortality following lower respiratory infection (LRI). To better inform treatment decisions, we determined influences on mortality following LRI among antibiotic-treated and non-antibiotic-treated residents in 2 populations.Observational, prospective, cohort studies.Ninety-seven nursing homes (36 US, 61 Netherlands).Residents (1044 US, 513 Netherlands) who met a standardized study definition for LRI.Demographics, symptoms and physical findings of LRI, functional status, major illness diagnoses, dementia status, treatments, and date of death within 6 months after diagnosis.We estimated a 2-period (0-14/15-90 days) weighted proportional hazards model of mortality for antibiotic-treated (n = 1280) and non-antibiotic-treated (n = 277) residents; both weights and regressors provide "doubly robust" risk adjustment-for LRI (illness) severity using a prognostic score and for nonrandom receipt of antibiotic treatment using a propensity score.In both the United States and the Netherlands, 14-day mortality was associated with three factors-LRI severity, water intake at diagnosis, and antibiotic use (not directly by severe dementia)-that accounted for 82% or, sequentially, 39%, 42%, and 1% of the cross-national mortality difference. The LRI Severity Score (based only on at-diagnosis eating dependency, pulse rate, decreased alertness, and breathing difficulty, with adequate discrimination [c ≥ 0.74] and calibration, and cross-indexed to commonly used LRI mortality measures) was related to mortality through 90 days, regardless of treatment. With sufficient water intake at diagnosis, 14-day mortality was unrelated to not receiving antibiotic treatment (adjusted hazard ratio [AHR], 1.20; 95% confidence interval, 0.70-2.04); insufficient water intake was related to increased 14-day mortality with antibiotics (AHR, 1.90; 1.38-2.60) or without (AHR, 7.12; 4.83-10.5). After 14 days, relative mortality worsened for antibiotic-treated residents with insufficient water intake. Inadequate water intake was related to increased eating dependence at onset of the LRI (OR, 4.2; 3.0-5.8).LRI severity, water intake, and antibiotic use explain mortality in both studies and reconcile cross-study Dutch/US 14-day mortality differences. LRI severity, derived at 14 days, is related to mortality through 90 days, regardless of treatment, and is key to risk adjustment. With adequate hydration, the survival benefit from antibiotic use is nonsignificant. Conversely, hydration, even without antibiotic treatment, appears central to curative treatment. In LRI guidelines, treatment, and research, the relative benefits of antibiotics and hydration for curative treatment should be addressed.
机译:在某些疗养院人口中,抗生素治疗可能不会降低下呼吸道感染(LRI)后的死亡率。为了更好地指导治疗决策,我们确定了2个人群中接受抗生素治疗和未接受抗生素治疗的居民对LRI死亡率的影响。观察性,前瞻性,队列研究。九十七个疗养院(美国36个,荷兰61个)。 1044 US,513荷兰)符合LRI的标准化研究定义.LRI的人口统计学,LRI的症状和体格检查,功能状态,重大疾病诊断,痴呆状态,治疗方法以及诊断后6个月内的死亡日期,我们估计为2 -抗生素治疗(n = 1280)和非抗生素治疗(n = 277)居民的-期间(0-14 / 15-90天)加权比例危险性死亡率模型;权重和回归指标均提供“双重稳健”的风险调整-使用预后评分对LRI(疾病)严重性进行评估,并使用倾向评分对非随机接受抗生素治疗进行评估。在美国和荷兰,14天死亡率与LRI严重性,诊断时的饮水量和抗生素使用(不是直接由严重痴呆引起)这三个因素占跨国死亡率差异的82%,或依次为39%,42%和1%。 LRI严重度评分(仅基于诊断时的饮食依赖,脉搏频率,警觉性和呼吸困难,具有充分的辨别力[c≥0.74]和校准,并与常用的LRI死亡率指标进行交叉索引)与死亡率相关持续90天,无论治疗如何。诊断时只要摄入足够的水,则14天死亡率与不接受抗生素治疗无关(调整后的危险比[AHR]为1.20; 95%的置信区间为0.70-2.04)。摄入水不足与使用抗生素(AHR,1.90; 1.38-2.60)或不使用抗生素(AHR,7.12; 4.83-10.5)的14天死亡率增加有关。 14天后,饮水量不足的抗生素治疗居民的相对死亡率恶化。摄入水不足与LRI发作时进食依赖性增加有关(OR,4.2; 3.0-5.8).LRI的严重程度,摄入水量和使用抗生素可解释两项研究的死亡率,并协调荷兰/美国14天死亡率的交叉研究差异。无论治疗如何,LRI严重性(在14天时得出)都与90天之内的死亡率有关,并且是风险调整的关键。补充足够的水分后,使用抗生素对生存的影响并不显着。相反,即使不进行抗生素治疗,水合似乎也是治疗的关键。在LRI指南,治疗和研究中,应解决抗生素和水合作用对治疗的相对益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号